Antimicrobial resistance resources

UICC resources and tools

This page regroups important resources on antimicrobial resistance, material for UICC's members and partners, infographics, videos and other important documents and links.

The threat of antimicrobial resistance to cancer treatment and survival is a priority for UICC. Currently, knowledge and awareness of the impact of antimicrobial resistance on cancer outcomes within the cancer community is low. It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and strategies for infection control.

In this regard, UICC will develop information to increase awareness and support the cancer community to come together and drive policy change, taking forward the WHO global action plan on antimicrobial resistance.

AMR Supplement

To sustain focus on the issue and mobilize action on addressing AMR, a special supplement of AMR Control emphasizing the impact of AMR on cancer care outcomes and was launched at the World Cancer Congress 2022. Written by over 50 experts committed to researching the scale of AMR and to finding workable solutions, the supplement is an excellent reference for the cancer community as well as being a key resource for advocacy efforts.

AMR Infographics and graphs

How antibiotic resistance develops

Antibiotics get less effective

Antibiotics help our bodies to kill the types of bacteria that make us sick.

Antibiotic resistance

Some of the bacteria that make us sick get better at defending themselves against antibiotics, meaning resistant bacteria are harder to kill. This is called antibiotic resistance.​

Antibiotics help our bodies to kill bacteria that makes us sick

The resistant bacteria start to multiply, making our antibiotics less and less effective.

Image source: PHARMAC, NZ -

Causes of antimicrobial resistance

AMR news & blogs

Close-up of a person's hand, receiving treatment intravenously.
23 November 2022

Lack of access to antibiotics and antifungals compromise cancer care

Marking the end of World Antimicrobial (AMR) Awareness Week, Fatima Rafiqi and Marijn Verhoef of Access to Medicines Foundation offer insight into an AMR benchmarking tool that evaluates pharmaceutical companies to stimulate them in the areas where they have the biggest potential and responsibility to limit AMR.

Man wearing a mask undergoing cancer treatment
17 November 2022

What can be done about drug resistance?

Marking the start of World Antimicrobial Resistance Awareness Week (WAAW), UICC reiterates recommendations from an essential supplement on AMR to reduce misuse and improve infection control and research and development.

Logo for UICC's let's talk cancer podcast, a globe wearing headphones
10 November 2022

Podcast "Let's Talk Cancer" – Antimicrobial Resistance: a silent pandemic

On the occasion of World Antimicrobial Awareness Week (WAAW), Kevin Outterson of CARB-X, talks about the threat of AMR, in particular for cancer patients – and what is being done to address AMR.

Person holding a blister pack of medicine
7 July 2022

UICC Editorial in the Bangkok Post: "Drug resistance is killing millions"

There is an urgent need for a global framework to address antimicrobial resistance, which has become a leading cause of death worldwide and poses a serious life threat to people living with cancer.

Woman in white blouse reaching for medication on a shelf
11 May 2022

Invest in nursing education to strengthen the fight against antimicrobial resistance

Marking International Nurses Day on 12 May, Howard Catton explains how investing early in nurses’ education on antibiotics can help address the growing problem of antimicrobial resistance.

Woman undergoing cancer treatment at FUCAM in Mexico. Photo by Adán Jardón (c) UICC 2021.
24 November 2021

Drug-resistant infections are undermining cancer care: better global data is key

Closing World Antimicrobial Awareness Week (18-24 November), Gemma Buckland-Merrett explains how better global data can support action to curb drug-resistant infections and save modern medicine.

AMR external documents & links

Useful links for further reading


Last update: 
Thursday 20 October 2022